Vulvar discharge syndrome in loosely housed Finnish pigs: prevalence and evaluation of vaginoscopy, bacteriology and cytology

Reproduction in Domestic Animals = Zuchthygiene
J OravainenO A T Peltoniemi

Abstract

A total of 21 sow herds were randomly chosen to determine the prevalence of vulvar discharge syndrome (VDS) in loosely housed sows. The median VDS prevalence was low as expected, 0% (range 0-4.5%). Nine of the 655 animals examined (1.4%, 95% CI 0.5-2.3) displayed signs of VDS in 21 non-problem herds. In addition, five VDS problem farms were visited to gather more animals affected with the syndrome in order to estimate which methods of examination are useful. Altogether, 19 VDS animals and 19 healthy controls were found, inspected and sampled. Ten of the VDS animals (53%) and three of the controls (16%) were positive in bacterial culture (p = 0.04) taken with a guarded swab from the anterior vagina. In addition, 94% of VDS animals had a positive vaginoscopic examination result and the corresponding figure in the control sows was 28% (p < 0.0002). Cytological smears were classified as positive in 37% of the case sows and in 5% of the control sows (p = 0.04). Detection of vulvar discharge was associated with vaginoscopic examination findings (p = 0.0005) and with bacteriology (p = 0.04), but not with leucocyte counts (p = 0.07). Susceptibility testing was performed on pure bacterial cultures. Totally, 7 (44%) of 16 isolates were c...Continue Reading

References

Nov 1, 1992·The Veterinary Clinics of North America. Food Animal Practice·S A Dee
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W HoeltlM Marberger
Sep 6, 1986·The Veterinary Record·M R Muirhead
Apr 1, 1981·Applied and Environmental Microbiology·I M RobinsonJ A Bucklin
Aug 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·H BrockD Bidal
Aug 15, 2001·Folia Microbiologica·G AvgustinM Peterka
Feb 2, 2002·Applied and Environmental Microbiology·Thomas D LeserKristian Møller
Nov 21, 2002·Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine·M WoldemeskelM Wendt
Dec 17, 2002·Symposium Series·C J Teale
Apr 28, 2004·Emerging Infectious Diseases·Daniel EladMichael Bernstein
May 1, 2004·American Journal of Obstetrics and Gynecology·Ronald S GibbsMichael P Sherman
Nov 30, 2004·Expert Review of Anti-infective Therapy·Jeanne M Marrazzo
May 10, 2006·The Journal of Allergy and Clinical Immunology·Luigi NotarangeloUNKNOWN International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee
Nov 17, 2006·Reproduction in Domestic Animals = Zuchthygiene·J OravainenOat Peltoniemi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.